Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.
2.

[Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno-2 study].

Gaede PH, Jepsen PV, Parving HH, Pedersen OB.

Ugeskr Laeger. 1999 Jul 26;161(30):4277-85. Danish.

PMID:
10439688
3.

Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design.

Shikata K, Haneda M, Koya D, Suzuki Y, Tomino Y, Yamada K, Maeda S, Kawakami N, Uzu T, Nishimura M, Sato C, Ogawa D, Makino H; DNETT-Japan Study Group.

Diabetes Res Clin Pract. 2010 Feb;87(2):228-32. doi: 10.1016/j.diabres.2009.09.025. Epub 2009 Nov 4.

PMID:
19889469
4.

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O.

N Engl J Med. 2003 Jan 30;348(5):383-93.

5.
6.
8.
9.
12.

Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R.

Arch Intern Med. 1998 May 11;158(9):998-1004.

PMID:
9588433
13.

Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

Estacio RO, Jeffers BW, Gifford N, Schrier RW.

Diabetes Care. 2000 Apr;23 Suppl 2:B54-64.

PMID:
10860192
14.

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M.

Diabetes Res Clin Pract. 1995 May;28(2):103-17.

PMID:
7587918
15.
16.

Treatment of microalbuminuria in patients with type 2 diabetes mellitus.

Jerums G, MacIsaac RJ.

Treat Endocrinol. 2002;1(3):163-73. Review.

PMID:
15799209
18.
19.
20.

Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study.

Wake N, Hisashige A, Katayama T, Kishikawa H, Ohkubo Y, Sakai M, Araki E, Shichiri M.

Diabetes Res Clin Pract. 2000 Jun;48(3):201-10.

PMID:
10802159

Supplemental Content

Support Center